Interesting facts
Interesting Facts About 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
The compound 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione, often referred to as a complex anthracene derivative, exhibits remarkable properties and applications in the field of chemistry and materials science. Here are some fascinating aspects of this compound:
- Anthracene Core: This compound features an anthracene structure, which is known for its stability and ability to form strong π-π interactions, making it an excellent candidate for organic semiconductor applications.
- Biological Significance: Compounds with similar structures are often studied for their potential use in medicinal chemistry, particularly regarding their behavior in biological systems and possible anti-cancer properties.
- Functionalization: The presence of hydroxyl and amino groups enhances its solubility and reactivity, allowing for further modifications that can tune its chemical properties for specific applications.
- Fluorescent Properties: Many anthracene derivatives exhibit fluorescence. This property can be leveraged in various applications, such as in sensors, light-emitting devices, and biological imaging.
- Multi-Activity: The compound is a part of a larger class of polycyclic aromatic compounds that can exhibit multiple activities, including anti-bacterial and anti-fungal, contributing to ongoing research in pharmaceutical development.
In summary, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione stands out not only for its complex structure but also for its diverse applications in science and technology. A notable quote related to such compounds is: "In every molecule, there lies a story waiting to be unraveled." This compound represents the intersection of chemistry, biology, and materials science, opening doors to exciting research opportunities.
Synonyms
mitoxantrone
65271-80-9
Mitozantrone
Mitoxanthrone
Mitoxantron
Mitoxantrona
DHAQ
Mitoxantronum
Misostol
Mitoxantrone [INN]
Mitoxantronum [INN-Latin]
Mitoxantrona [INN-Spanish]
CCRIS 7604
NSC 279836
NSC-279836
UNII-BZ114NVM5P
DHAD
BZ114NVM5P
NSC279836
1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone
1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
BRN 2795126
Mitoxantrone (INN)
Mitoxantrone free base
CHEBI:50729
5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone
1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione
1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon
1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione
1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione
1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-
MLS002703044
DTXSID4046947
65271-80-9 (free base)
MFCD00242942
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-
NSC299195
NSC301739
MITOXANTRONE (IARC)
MITOXANTRONE [IARC]
Mitoxantronum (INN-Latin)
Mitoxantrona (INN-Spanish)
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione
MIX
MLS001333711
9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-
Misostol (TN)
NCGC00015693-02
Mitoxantrone (free base)
SMR000058480
Mitoxantrone [INN:BAN]
CAS-70476-82-3
DHAQ (*Diacetate salt*)
SR-01000076001
Mitoxantrone base
2fum
1,4-DIHYDROXY-5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-9,10-ANTHRACENEDIONE
1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione
1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione
Immunex (Salt/Mix)
dihydroxyanthracenedione
Spectrum_001655
Mitoxantrone (Standard)
CHEMBL58
Prestwick0_000385
Prestwick1_000385
Prestwick2_000385
Prestwick3_000385
Spectrum2_000908
Spectrum3_001590
Spectrum4_000866
Spectrum5_001205
Lopac-M-6545
MITOXANTRONE [MI]
cid_4212
Neuro_000153
SCHEMBL3000
MITOXANTRONE [VANDF]
BIDD:PXR0181
Lopac0_000779
BSPBio_000569
BSPBio_003160
KBioGR_001531
KBioSS_002135
DivK1c_000516
MITOXANTRONE [WHO-DD]
SPBio_000756
SPBio_002490
BPBio1_000627
GTPL7242
DTXCID2026947
BDBM67690
cid_5458171
KBio1_000516
KBio2_002135
KBio2_004703
KBio2_007271
KBio3_002660
L01DB07
NINDS_000516
GLXC-03038
HMS2090D05
HMS3655E20
KUC108634N
BCP02861
CCG-36371
HY-13502R
s1889
STK631833
Mitoxantrone hydrochloride (Salt/Mix)
AKOS005564036
BCP9000931
DB01204
FD26022
KSC-19-204
SDCCGSBI-0050757.P004
IDI1_000516
SMP2_000179
NCGC00015693-01
NCGC00015693-03
NCGC00015693-04
NCGC00015693-05
NCGC00015693-06
NCGC00015693-08
NCGC00015693-13
NCGC00015693-23
NCGC00162251-01
AC-37649
AS-35321
HY-13502
MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE
NCI60_002276
NCI60_002535
SMR001549953
SY226320
SBI-0050757.P003
AB00053716
M3133
NS00008439
SW196745-6
VU0244399-2
D08224
EN300-117257
AB00053716-18
AB00053716-19
AB00053716-22
AB00053716_23
AB00053716_24
Q239426
SR-01000076001-7
BRD-K21680192-001-01-5
BRD-K21680192-001-11-4
BRD-K21680192-300-05-2
BRD-K21680192-300-07-8
BRD-K21680192-300-09-4
BRD-K21680192-300-10-2
BRD-K21680192-300-12-8
BRD-K21680192-300-14-4
BRD-K21680192-300-15-1
BRD-K21680192-300-16-9
1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone
1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone
1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone
9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-
1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione
1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone
1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride
1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride
1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride
1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione;DHAQ;NSC-279836
MITOXANTRONE; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
Solubility of 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
The solubility of the compound 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione (C27H29N1O11) presents a complex profile due to its intricate molecular structure. Understanding the solubility can be broken down into several key points:
The solubility behavior can be summarized with the phrase: "Like dissolves like." Therefore, while this compound is likely soluble in polar solvents, its solubility in non-polar solvents will be significantly limited. Overall, the exploration of solubility for this compound is essential for its practical applications in diverse chemical environments.